公开(公告)号：WO0220090A2

公开(公告)日：2002-03-14

申请号：PCT/EP0110448

申请日：2001-09-10

Applicant: NOVARTIS AG ,  NOVARTIS ERFIND VERWALT GMBH ,  BATEMAN SIMON DAVID ,  GIMONA ALBERTO ,  HOLINEJ JURIJ ,  HUELS JASPER ,  JAYAWARDENE SUMEDHA ,  KARABELAS ARGERIS JERRY ,  KHALED MAHA Y ,  KARNACHI ANEES ABDULQUADAR ,  NIC LOCHLAINN EIMEAR MAIRIN ,  MACERATA RICHARD ,  SLOAN VICTOR

Inventor： BATEMAN SIMON DAVID ,  GIMONA ALBERTO ,  HOLINEJ JURIJ ,  HUELS JASPER ,  JAYAWARDENE SUMEDHA ,  KARABELAS ARGERIS JERRY ,  KHALED MAHA Y ,  KARNACHI ANEES ABDULQUADAR ,  NIC LOCHLAINN EIMEAR MAIRIN ,  MACERATA RICHARD ,  SLOAN VICTOR

IPC: A61K47/02 ,  A61K9/20 ,  A61K9/28 ,  A61K31/195 ,  A61K31/196 ,  A61K47/12 ,  A61K47/26 ,  A61K47/32 ,  A61K47/38 ,  A61P5/00 ,  A61P29/00 ,  A61P43/00

CPC classification number: A61K31/195 ,  A61K9/2027 ,  A61K9/2054 ,  A61K9/2077 ,  A61K9/2866 ,  A61K31/196

Abstract: A composition for treating a cyclooxygenase-2 dependent disorder or condition comprising: 5-methyl-2(2'-chloro-6'-fluoroanilino)phenylacetic acid or a pharmaceutically acceptable salt thereof, which composition is an immediate release pharmaceutical composition for treatment of said disorder or condition for about 24 hours.

Abstract translation: 一种用于治疗环氧合酶-2依赖性病症或病症的组合物，其包含：5-甲基-2（2'-氯-6'-氟苯胺基）苯乙酸或其药学上可接受的盐，该组合物是用于治疗 所述疾病或病症约24小时。

公开(公告)号：WO2002020090A3

公开(公告)日：2002-03-14

申请号：PCT/EP2001/010448

申请日：2001-09-10

Applicant: NOVARTIS AG ,  NOVARTIS PHARMA GMBH ,  BATEMAN, Simon, David ,  GIMONA, Alberto ,  HOLINEJ, Jurij ,  HUELS, Jasper ,  JAYAWARDENE, Sumedha ,  KARABELAS, Argeris, Jerry ,  KHALED, Maha, Y. ,  KARNACHI, Anees, Abdulquadar ,  NIC LOCHLAINN, Eimear, Mairin ,  MACERATA, Richard ,  SLOAN, Victor

Inventor： BATEMAN, Simon, David ,  GIMONA, Alberto ,  HOLINEJ, Jurij ,  HUELS, Jasper ,  JAYAWARDENE, Sumedha ,  KARABELAS, Argeris, Jerry ,  KHALED, Maha, Y. ,  KARNACHI, Anees, Abdulquadar ,  NIC LOCHLAINN, Eimear, Mairin ,  MACERATA, Richard ,  SLOAN, Victor

IPC: A61P5/00

Abstract: A composition for treating a cyclooxygenase-2 dependent disorder or condition comprising: 5-methyl-2(2'-chloro-6'-fluoroanilino)phenylacetic acid or a pharmaceutically acceptable salt thereof, which composition is an immediate release pharmaceutical composition for treatment of said disorder or condition for about 24 hours.

公开(公告)号：WO0220090A9

公开(公告)日：2003-10-30

申请号：PCT/EP0110448

申请日：2001-09-10

Applicant: NOVARTIS AG ,  NOVARTIS PHARMA GMBH ,  BATEMAN SIMON DAVID ,  GIMONA ALBERTO ,  HOLINEJ JURIJ ,  HUELS JASPER ,  JAYAWARDENE SUMEDHA ,  KARABELAS ARGERIS JERRY ,  KHALED MAHA Y ,  KARNACHI ANEES ABDULQUADAR ,  NIC LOCHLAINN EIMEAR MAIRIN ,  MACERATA RICHARD ,  SLOAN VICTOR

Inventor： BATEMAN SIMON DAVID ,  GIMONA ALBERTO ,  HOLINEJ JURIJ ,  HUELS JASPER ,  JAYAWARDENE SUMEDHA ,  KARABELAS ARGERIS JERRY ,  KHALED MAHA Y ,  KARNACHI ANEES ABDULQUADAR ,  NIC LOCHLAINN EIMEAR MAIRIN ,  MACERATA RICHARD ,  SLOAN VICTOR

IPC: A61K47/02 ,  A61K9/20 ,  A61K9/28 ,  A61K31/195 ,  A61K31/196 ,  A61K47/12 ,  A61K47/26 ,  A61K47/32 ,  A61K47/38 ,  A61P5/00 ,  A61P29/00 ,  A61P43/00

CPC classification number: A61K31/195 ,  A61K9/2027 ,  A61K9/2054 ,  A61K9/2077 ,  A61K9/2866 ,  A61K31/196

Abstract: A composition for treating a cyclooxygenase-2 dependent disorder or condition comprising: 5-methyl-2(2'-chloro-6'-fluoroanilino)phenylacetic acid or a pharmaceutically acceptable salt thereof, which composition is an immediate release pharmaceutical composition for treatment of said disorder or condition for about 24 hours.

Abstract translation: 一种用于治疗环氧合酶-2依赖性病症或病症的组合物，其包含：5-甲基-2（2'-氯-6'-氟苯胺基）苯乙酸或其药学上可接受的盐，该组合物是用于治疗 所述疾病或病症约24小时。